Euro Dementia 2019 organizing committee are esteemed to invite in upcoming "12th World Congress on Dementia and Alzheimer Rehabilitation’’ scheduled during April 11-12, 2019 in Stockholm, Sweden. With honour we welcome you to join the congress which is mainly based on the theme ‘’Different innovative approaches to treat mental disorder diseases specially Dementia & Alzheimer’s disease and their rehabilitation’’.
European conferences anticipates more than 500 participants around the globe to experience thought provoking keynote lectures, oral & poster presentations. This year conference will offer ample opportunities for all stakeholders working on Dementia, Alzheimer’s and neurologic disorder to expose their research work.
Dementia 2019 is organizing an outstanding scientific exhibition/program and anticipates the world's leading neurologists, health professionals involved in the profession and practice of neuroscience. The neurological disorder event will also reflect interest of specialists in the clinical research on Dementia rehabilitation. This dementia congress is for people to take part and gain a better understanding of such diseases, to access treatment as well as information and advice. This is an effort to make possible interactions among world leading scientists, research scholars, professionals, young researchers, principal investigators, experts and researchers working on brain from both academia and health care industry, business delegates, scientists and students from different parts of the world to exchange their knowledge and conduct dementia symposia, show experiments with new innovative techniques that disseminate information about clinical tradition, best practices, skills and knowledge in the field of neuroscience.This event will provide an international forum for the dissemination of original research results, new ideas and practical development experiences all over the globe.
In Dementia and Alzheimer’s rehabilitation 2019 conference, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of psychiatric disorder and mental health.
Within this splendid setting, we plan to deliver a conference that will exceed your expectations. Our event aims to makesociety dementia feel safe and to create a familiar environment for them.
During this year’s conference, we hope that you will seize the opportunity to rekindle on-going connections and spark new ones with your colleagues from around the globe.
Dementia Rehabilitation describes a set of symptoms include memory loss and difficulties with thinking or reasoning that reduce a person ability to perform everyday activities. Dementia is mainly caused when the brain is damaged by diseases, such as Alzheimer’s disease or a series of strokes. This disease mainly affects people over the age of 65 and the likelihood of developing dementia increases significantly with age. However, dementia can affect younger people too.
Conference scientific Tracks:
Track 1: Dementia
Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type.
1:Dementia with Lewy Bodies
2:Mixed dementia.
3:Frontotemporal dementia.
4:Normal pressure hydrocephalus
5:Signs and symptoms of dementia
Track 2: Alzheimer’s Disease
Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is not a normal part of aging.
1:Risk Factors of alzheimers
2:Diagnosis of alzheimers
3:Treatments of alzheimers
4:Clinical Studies of alzheimers
5:Alzheimer’s disease Pathophysiology and Disease Mechanisms
Track 3: Dementia and Ageing
Aging: Not being able to remember details of a conversation or event that took place a year ago, Not being able to remember the name of an acquaintance, Forgetting things and events occasionally, Occasionally have difficulty finding words, You are worried about your memory but your relatives are not..
Dementia: Not being able to recall details of recent events or conversations, Not recognizing or knowing the names of family members, Forgetting things or events more frequently, Frequent pauses and substitutions when finding words, Your relatives are worried about your memory, but you are not aware of any problems
1:Neuro-anatomical changes in ageing
2:Risk factors of cognitive decline
3:Granulovacuolar degeneration
4:Changes in cerebral cortical microvasculature
5:Advances of research in ageing and dementia
Vascular dementia occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.
1:Vascular dementia prognosis
2:Young onset dementia
3:Multi-infarct dementia
4:Mixed dementia
5:Parkinson dementia
6:Advences in vascular dementia therapy
Geriatrics or geriatric medication may be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. there's no set age at that patients are also underneath the care of a specialist or geriatric .
1:Delirium
2:Mild and Major Neurocognitive Disorder
Track 6: Animal Models in Dementia
The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.
1:Neurobehavioral Toxicology Testing
2:pre-clinical testing and clinical translation
3:Protein-protein interactions
4:Genetics of translational models
5:Animal models of human cognitive aging
Track 7: Amyloid Protein in Alzheimer’s and Dementia
Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau.
1:Amyloid Imaging
2:FDG-PET
3:Amyloid Immunotherapy
The developing number of vascular dementia patients prompts both approach, monetary and wellbeing association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance dementia patients and guardians care and administrations conveyance.
1:Advances in dementia care management
2:Dementia care management program
3:Undernutrition and obesity in dementia
4:Advance care planning
People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects apraxia, agnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities.
1:Dementia nursing care plan
2:Music therapy in dementia
3: Dementia Physiotherapy
4:Clinical features of dementia
5: Dementia Therapeutic intervention
Early discovery and exact analysis are critical, as vascular dementia is at any rate halfway preventable. Ischemic changes in the cerebrum are irreversible, however the patient with vascular dementia can exhibit times of solidness or even gentle change. Since stroke is a basic piece of vascular dementia, the objective is to forestall new strokes. This is endeavored through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus.
1:Primary mental health care and nursing
2:Psychopharmacological treatment
3:Advanced drugs for dementia
4:Cognitive behavioral therapy
5:Family therapy in nursing
For conference attendance and participation only Business Visa should be applied. Contact your nearest travel agent/visa information center/ Sweden Embassy for the correct application form.
All visas for visiting / Sweden shall be processed by respective authorities only upon submission of proper documents through proper channel.
In case of non-furnishing of documents, non-adherence to guidelines visas shall be cancelled by respective authorities.
The minimum supportive documents that might be required while applying for / Sweden visa include:
Letter of invitation,
Abstract acceptance letter (if speaker),
Registration payment receipt,
Accommodation confirmation letter issued under conference letter head.
For letter of invitation and accommodation confirmation, payment of registration fees and accommodation charges is a pre-requisite.
Mandate documents required from conference secretariat should be obtained only through Edward Parker
For more details please contact:
Edward Parker
Program Manager
Euro Dementia Meetings 2019
E: dementia@europemeet.com
E: dementia2019meetings@gmail.com
Apeksha Shrivastava
Chithapuram Satheesh
Romeo Vitelli
Panteleimon Giannakopoulos
Robert Hedaya
Junyang Wang
Bao Wangxiao
Ellie Robinson-Carter
Dheeraj Chaudhary
Effrosyni Koutsouraki
